Study finds more than 40 percent of prostate biopsies could be avoided with new blood test
A multi-center study that validates the clinical performance of IsoPSA—a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen (PSA) - will ...
May 18, 2018
0
7